Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Ribociclib Succinate and Letrozole

Placeholder slot
 (RY-boh-SY-klib SUK-sih-nayt … LEH-truh-zole)

Kisqali Femara Co-Pack combines two drugs into one package: ribociclib succinate (Kisqali) and letrozole (Femara). Ribociclib succinate is a targeted therapy drug that blocks proteins called CDK4 and CDK6 that cancer cells need to grow. Letrozole is a hormone therapy and targeted therapy drug that blocks a protein called aromatase, which the body uses to make estrogen. Blocking aromatase lowers estrogen levels, which helps slow or stop the growth of breast cancer cells that need estrogen to grow.

US Brand Name(s)
Kisqali Femara Co-Pack
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

The ribociclib succinate and letrozole co-pack is approved to treat:

Ribociclib succinate and letrozole are also available separately as ribociclib succinate and letrozole. For more information that may apply to these drugs, see the Drug Information Summaries for Ribociclib Succinate and Letrozole.

More About Ribociclib Succinate and Letrozole

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Targeted Therapy to Treat Cancer

Combo of Ribociclib, Letrozole Improves Survival in Advanced Breast Cancer

Hormone Therapy to Treat Breast Cancer

Clinical Trials Accepting Patients

Find Clinical Trials for Ribociclib Succinate/letrozole - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated:
Email